Varicella zoster virus in human and rat tissue specimens

  • P. W. Annunziato
  • O. Lungu
  • C. Panagiotidis
Conference paper

Summary

The limited supple of appropriate tissues for study has been an impediment to investigations of varicella zoster virus (VZV) latency. Human dorsal root ganglia (DRG) harboring latent virus are not plentiful and are not amenable to manipulation for studying the events surrounding the establishment, maintenance, and cessation of latency. An alternative to studies in human DRG is the rat model of latency, which appears to provide a reliable method of investigating VZV latency. Other alternatives include studies in other human tissues involved in VZV pathogenesis. In order to improve our understanding of the establishment and cessation of latency, we performed comparative immunohistochemical analysis of chickenpox and zoster skin lesions. This analysis revealed that during primary infection and reactivation productive VZV infection occurs in a variety of cell types and that the major VZV DNA binding protein, ORF29p, is present in peripheral axons early during the course of chickenpox. VZV latency was studied in the rat model by in situ hybridization and compared with similar studies performed in human DRG containing latent virus, confirming that VZV DNA persists in the same sites in DRG of the two species.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Annunziato P, LaRussa P, Lee P, Steinberg S, Lungu O, Gershon A, Silverstein S (1998) Evidence of latent varicella zoster virus in rat dorsal root ganglia. J Infect Dis 178 [Suppl] 11: S48–51PubMedCrossRefGoogle Scholar
  2. 2.
    Annunziato P, Lungu O, Panagiotidis C, Zhang J, Silvers D, Gershon A, Silverstein S (2000) Varicella-zoster virus proteins in skin lesions: implications for a novel role of ORF29p in chickenpox. J Virol 74: 2005–2010PubMedCrossRefGoogle Scholar
  3. 3.
    Cohen J, Straus S (1996) Varicella-zoster virus and its replication, vol 2, 3rd ed. Lippincott-Raven, PhiladelphiaGoogle Scholar
  4. 4.
    Cohrs RJ, Barbour M, Gilden D (1996) Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21,29,62, and 63 in a cDNA library enriched for VZV RNA. J Virol 70: 2789–2796PubMedGoogle Scholar
  5. 5.
    Cohrs RJ, Barbour MB, Mahlingham R, Wellish M, Gilden D (1995) Varicella-zoster virus (VZV) transcription during latency in human ganglia: prevalence of VZV gene 21 transcripts in latently infected human ganglia. J Virol 69: 2674–2678PubMedGoogle Scholar
  6. 6.
    Cohrs RJ, Srock K, Barbour MB, Owens G, Mahlingham R, Devlin M, Wellish M, Gilden D (1994) Varicella-zoster virus (VZV) transcription during latency in human ganglia: construction of a cDNA library from latently infected human trigeminal ganglia and detection of a VZV transcript. J Virol 68: 7900–7908PubMedGoogle Scholar
  7. 7.
    Croen KD, Ostrove JM, Dragovic LY, Straus SE (1988) Patterns of gene expression and sites of latency in human ganglia are different for varicella-zoster and herpes simplex viruses. Proc Natl Acad Sci USA 85: 9773–9777PubMedCrossRefGoogle Scholar
  8. 8.
    Debrus S, Sadzot-Delvaux C, Nikkels AF, Piette J, Rentier B (1995) Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J Virol 69: 3240–3245PubMedGoogle Scholar
  9. 9.
    Gilden D, Rozenman Y, Murray R, Devlin M, Vafai A (1987) Detection of varicellazoster virus nucleic acid in neurons of normal human thoracic ganglia. Ann Neurol 22: 337–380CrossRefGoogle Scholar
  10. 10.
    Kinchington P, Hougland J, Arvin A, Ruyechan W, Hay J (1992) The varicella-zoster virus immediate-early protein 1E62 is a major component of virus particles. J Virol 66: 359–366PubMedGoogle Scholar
  11. 11.
    Kinchington PR, Bookey D, Turse SE (1995) The transcriptional regulatory proteins encoded by varicella-zoster virus are open reading frames (ORFs) 4 and 63, but not ORF 61, are associated with purified virus particles. J Virol 69: 4274–4282PubMedGoogle Scholar
  12. 12.
    Lungu O, Annunziato P, Gershon A, Stegatis S, Josefson D, LaRussa P, Silverstein S (1995) Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc Natl Acad Sci USA 92: 10980–10984PubMedCrossRefGoogle Scholar
  13. 13.
    Lungu O, Panagiotidis C, Annunziato P, Gershon A, Silverstein S (1998) Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc Natl Acad Sci USA 95: 7080–7085PubMedCrossRefGoogle Scholar
  14. 14.
    Mahalingham R, Wellish M, Wolf W, Dueland AN, Cohrs R, Vafai A, Gilden D (1990) Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med 323: 627–631CrossRefGoogle Scholar
  15. 15.
    Meier JL, Holman RP, Croen KD, Smialek JE, Straus SE (1993) Varicella-zoster virus transcription in human trigeminal ganglia. Virology 193: 193–200PubMedCrossRefGoogle Scholar
  16. 16.
    Sadzot-Delvaux C, Merville-Louis M-P, Delree P, Marc P, Moonen G, Rentier B (1990) An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia. J Neurosci Res 26: 83–89PubMedCrossRefGoogle Scholar
  17. 17.
    Schwartz J (1984) Biochemical control mechanisms in synaptic transmissions. In: Kandel E, Schwartz J (eds) Principles of neural science. Elsevier, New York, pp 121–131Google Scholar

Copyright information

© Springer-Verlag Wien 2001

Authors and Affiliations

  • P. W. Annunziato
    • 1
  • O. Lungu
    • 2
  • C. Panagiotidis
    • 3
  1. 1.Department of PediatricsColumbia UniversityUSA
  2. 2.Department of Microbiology, College of Physicians and SurgeonsColumbia UniversityNew YorkUSA
  3. 3.Department of Pharmaceutical SciencesAristotle UniversityThessalonikiGreece

Personalised recommendations